The Latin America, Middle East and Africa Hydrogel-based Drug Delivery System Market would witness market growth of 9.1% CAGR during the forecast period (2021-2027).
Natural & synthetic hydrogels are integrated to formulate hybrid hydrogels. The phenomenon of hybrid polymerization is utilized in the manufacturing of an improved version known as SMART hydrogel. These SMART hydrogels are stimuli-responsive and distinct from traditional hydrogels since the drug release is reliant on physical or chemical stimuli. The physical stimuli consist of pressure, magnetic, temperature, and electric field allowing targeted drug delivery utilizing hydrogels. For example, a PH sensitive was made by integrating polyacrylic acid along with natural polymers.
The presence of emerging nations like Nigeria, where the healthcare structure is not very strong that might slow down the products’ demand in these nations. In addition, the limited spending of the people in this region has hindered the demand for the hydrogel-based drug delivery system in this region. However, countries like South Africa are increasingly spending on the healthcare system and the governments of such countries are increasing their budget on building advanced healthcare systems.
Moreover, the adoption rate of the advanced or improved technologies in this region is comparatively lower than in other regions, which would further limit the demand for the hydrogel-based drug delivery system market in LAMEA region.
The Ocular market dominated the South Africa Hydrogel-based Drug Delivery System Market by Delivery Route in 2020, thereby, achieving a market value of $39.4 Million by 2027. The Subcutaneous market is showcasing a CAGR of 9.7% during (2021 - 2027). Additionally, The Oral Cavity market is expected to witness highest CAGR of 10.2% during (2021 - 2027).
Based on Polymer Origin, the market is segmented into Synthetic, Natural and Hybrid. Based on Delivery Route, the market is segmented into Ocular, Subcutaneous, Oral Cavity, Topical and Other Delivery Routes. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Hydrogel-based Drug System Market is Predict to reach $9.3 Billion by 2027, at a CAGR of 8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, Bausch Health Companies, Inc., Medtronic PLC, Galderma S.A., Endo International PLC, Ferring Holdings SA, Akorn Operating Company LLC, Tolmar Pharmaceuticals, Inc., Blairex Laboratories, Inc., and Ocular Therapeutix, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Polymer Origin
By Delivery Route
- Ocular
- Subcutaneous
- Oral Cavity
- Topical
- Other Delivery Routes
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Johnson & Johnson
- Bausch Health Companies, Inc.
- Medtronic PLC
- Galderma S.A.
- Endo International PLC
- Ferring Holdings SA
- Akorn Operating Company LLC
- Tolmar Pharmaceuticals, Inc.
- Blairex Laboratories, Inc.
- Ocular Therapeutix, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Hydrogel-based Drug System Market, by Polymer Origin
1.4.2 LAMEA Hydrogel-based Drug System Market, by Delivery Route
1.4.3 LAMEA Hydrogel-based Drug System Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Hydrogel-based Drug Delivery System Market by Polymer Origin
3.1 LAMEA Synthetic Market by Country
3.2 LAMEA Natural Market by Country
3.3 LAMEA Hybrid Market by Country
Chapter 4. LAMEA Hydrogel-based Drug Delivery System Market by Delivery Route
4.1 LAMEA Ocular Market by Country
4.2 LAMEA Subcutaneous Market by Country
4.3 LAMEA Oral Cavity Market by Country
4.4 LAMEA Topical Market by Country
4.5 LAMEA Other Delivery Routes Market by Country
Chapter 5. LAMEA Hydrogel-based Drug Delivery System Market by Country
5.1 Brazil Hydrogel-based Drug Delivery System Market
5.1.1 Brazil Hydrogel-based Drug Delivery System Market by Polymer Origin
5.1.2 Brazil Hydrogel-based Drug Delivery System Market by Delivery Route
5.2 Argentina Hydrogel-based Drug Delivery System Market
5.2.1 Argentina Hydrogel-based Drug Delivery System Market by Polymer Origin
5.2.2 Argentina Hydrogel-based Drug Delivery System Market by Delivery Route
5.3 UAE Hydrogel-based Drug Delivery System Market
5.3.1 UAE Hydrogel-based Drug Delivery System Market by Polymer Origin
5.3.2 UAE Hydrogel-based Drug Delivery System Market by Delivery Route
5.4 Saudi Arabia Hydrogel-based Drug Delivery System Market
5.4.1 Saudi Arabia Hydrogel-based Drug Delivery System Market by Polymer Origin
5.4.2 Saudi Arabia Hydrogel-based Drug Delivery System Market by Delivery Route
5.5 South Africa Hydrogel-based Drug Delivery System Market
5.5.1 South Africa Hydrogel-based Drug Delivery System Market by Polymer Origin
5.5.2 South Africa Hydrogel-based Drug Delivery System Market by Delivery Route
5.6 Nigeria Hydrogel-based Drug Delivery System Market
5.6.1 Nigeria Hydrogel-based Drug Delivery System Market by Polymer Origin
5.6.2 Nigeria Hydrogel-based Drug Delivery System Market by Delivery Route
5.7 Rest of LAMEA Hydrogel-based Drug Delivery System Market
5.7.1 Rest of LAMEA Hydrogel-based Drug Delivery System Market by Polymer Origin
5.7.2 Rest of LAMEA Hydrogel-based Drug Delivery System Market by Delivery Route
Chapter 6. Company Profiles
6.1 Johnson & Johnson
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental &Regional Analysis
6.1.4 Research & Development Expenses
6.2 Bausch Health Companies, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Partnerships, Collaborations, and Agreements:
6.2.5.2 Product Launches and Product Expansions:
6.3 Medtronic PLC
6.3.1 Company overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expenses
6.4 Galderma S.A.
6.4.1 Company Overview
6.4.2 Recent strategies and developments:
6.4.2.1 Partnerships, Collaborations, and Agreements:
6.4.2.2 Approvals & Trials:
6.5 Endo International PLC
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental Analysis
6.5.4 Research & Development Expenses
6.6 Ferring Holdings SA
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research and Development Expense
6.7 Akorn Operating Company LLC
6.7.1 Company Overview
6.7.2 Recent strategies and developments:
6.7.2.1 Approvals & Trials:
6.8 Tolmar Pharmaceuticals, Inc.
6.8.1 Company Overview
6.9 Blairex Laboratories, Inc.
6.9.1 Company Overview
6.10. Ocular Therapeutix, Inc.
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Research & Development Expenses
6.10.4 Recent strategies and developments:
6.10.4.1 Partnerships, Collaborations, and Agreements:
6.10.4.2 Approvals & Trials:
TABLE 1 LAMEA Hydrogel-based Drug Delivery System Market, 2017 - 2020, USD Million
TABLE 2 LAMEA Hydrogel-based Drug Delivery System Market, 2021 - 2027, USD Million
TABLE 3 LAMEA Hydrogel-based Drug Delivery System Market by Polymer Origin, 2017 - 2020, USD Million
TABLE 4 LAMEA Hydrogel-based Drug Delivery System Market by Polymer Origin, 2021 - 2027, USD Million
TABLE 5 LAMEA Synthetic Market by Country, 2017 - 2020, USD Million
TABLE 6 LAMEA Synthetic Market by Country, 2021 - 2027, USD Million
TABLE 7 LAMEA Natural Market by Country, 2017 - 2020, USD Million
TABLE 8 LAMEA Natural Market by Country, 2021 - 2027, USD Million
TABLE 9 LAMEA Hybrid Market by Country, 2017 - 2020, USD Million
TABLE 10 LAMEA Hybrid Market by Country, 2021 - 2027, USD Million
TABLE 11 LAMEA Hydrogel-based Drug Delivery System Market by Delivery Route, 2017 - 2020, USD Million
TABLE 12 LAMEA Hydrogel-based Drug Delivery System Market by Delivery Route, 2021 - 2027, USD Million
TABLE 13 LAMEA Ocular Market by Country, 2017 - 2020, USD Million
TABLE 14 LAMEA Ocular Market by Country, 2021 - 2027, USD Million
TABLE 15 LAMEA Subcutaneous Market by Country, 2017 - 2020, USD Million
TABLE 16 LAMEA Subcutaneous Market by Country, 2021 - 2027, USD Million
TABLE 17 LAMEA Oral Cavity Market by Country, 2017 - 2020, USD Million
TABLE 18 LAMEA Oral Cavity Market by Country, 2021 - 2027, USD Million
TABLE 19 LAMEA Topical Market by Country, 2017 - 2020, USD Million
TABLE 20 LAMEA Topical Market by Country, 2021 - 2027, USD Million
TABLE 21 LAMEA Other Delivery Routes Market by Country, 2017 - 2020, USD Million
TABLE 22 LAMEA Other Delivery Routes Market by Country, 2021 - 2027, USD Million
TABLE 23 LAMEA Hydrogel-based Drug Delivery System Market by Country, 2017 - 2020, USD Million
TABLE 24 LAMEA Hydrogel-based Drug Delivery System Market by Country, 2021 - 2027, USD Million
TABLE 25 Brazil Hydrogel-based Drug Delivery System Market, 2017 - 2020, USD Million
TABLE 26 Brazil Hydrogel-based Drug Delivery System Market, 2021 - 2027, USD Million
TABLE 27 Brazil Hydrogel-based Drug Delivery System Market by Polymer Origin, 2017 - 2020, USD Million
TABLE 28 Brazil Hydrogel-based Drug Delivery System Market by Polymer Origin, 2021 - 2027, USD Million
TABLE 29 Brazil Hydrogel-based Drug Delivery System Market by Delivery Route, 2017 - 2020, USD Million
TABLE 30 Brazil Hydrogel-based Drug Delivery System Market by Delivery Route, 2021 - 2027, USD Million
TABLE 31 Argentina Hydrogel-based Drug Delivery System Market, 2017 - 2020, USD Million
TABLE 32 Argentina Hydrogel-based Drug Delivery System Market, 2021 - 2027, USD Million
TABLE 33 Argentina Hydrogel-based Drug Delivery System Market by Polymer Origin, 2017 - 2020, USD Million
TABLE 34 Argentina Hydrogel-based Drug Delivery System Market by Polymer Origin, 2021 - 2027, USD Million
TABLE 35 Argentina Hydrogel-based Drug Delivery System Market by Delivery Route, 2017 - 2020, USD Million
TABLE 36 Argentina Hydrogel-based Drug Delivery System Market by Delivery Route, 2021 - 2027, USD Million
TABLE 37 UAE Hydrogel-based Drug Delivery System Market, 2017 - 2020, USD Million
TABLE 38 UAE Hydrogel-based Drug Delivery System Market, 2021 - 2027, USD Million
TABLE 39 UAE Hydrogel-based Drug Delivery System Market by Polymer Origin, 2017 - 2020, USD Million
TABLE 40 UAE Hydrogel-based Drug Delivery System Market by Polymer Origin, 2021 - 2027, USD Million
TABLE 41 UAE Hydrogel-based Drug Delivery System Market by Delivery Route, 2017 - 2020, USD Million
TABLE 42 UAE Hydrogel-based Drug Delivery System Market by Delivery Route, 2021 - 2027, USD Million
TABLE 43 Saudi Arabia Hydrogel-based Drug Delivery System Market, 2017 - 2020, USD Million
TABLE 44 Saudi Arabia Hydrogel-based Drug Delivery System Market, 2021 - 2027, USD Million
TABLE 45 Saudi Arabia Hydrogel-based Drug Delivery System Market by Polymer Origin, 2017 - 2020, USD Million
TABLE 46 Saudi Arabia Hydrogel-based Drug Delivery System Market by Polymer Origin, 2021 - 2027, USD Million
TABLE 47 Saudi Arabia Hydrogel-based Drug Delivery System Market by Delivery Route, 2017 - 2020, USD Million
TABLE 48 Saudi Arabia Hydrogel-based Drug Delivery System Market by Delivery Route, 2021 - 2027, USD Million
TABLE 49 South Africa Hydrogel-based Drug Delivery System Market, 2017 - 2020, USD Million
TABLE 50 South Africa Hydrogel-based Drug Delivery System Market, 2021 - 2027, USD Million
TABLE 51 South Africa Hydrogel-based Drug Delivery System Market by Polymer Origin, 2017 - 2020, USD Million
TABLE 52 South Africa Hydrogel-based Drug Delivery System Market by Polymer Origin, 2021 - 2027, USD Million
TABLE 53 South Africa Hydrogel-based Drug Delivery System Market by Delivery Route, 2017 - 2020, USD Million
TABLE 54 South Africa Hydrogel-based Drug Delivery System Market by Delivery Route, 2021 - 2027, USD Million
TABLE 55 Nigeria Hydrogel-based Drug Delivery System Market, 2017 - 2020, USD Million
TABLE 56 Nigeria Hydrogel-based Drug Delivery System Market, 2021 - 2027, USD Million
TABLE 57 Nigeria Hydrogel-based Drug Delivery System Market by Polymer Origin, 2017 - 2020, USD Million
TABLE 58 Nigeria Hydrogel-based Drug Delivery System Market by Polymer Origin, 2021 - 2027, USD Million
TABLE 59 Nigeria Hydrogel-based Drug Delivery System Market by Delivery Route, 2017 - 2020, USD Million
TABLE 60 Nigeria Hydrogel-based Drug Delivery System Market by Delivery Route, 2021 - 2027, USD Million
TABLE 61 Rest of LAMEA Hydrogel-based Drug Delivery System Market, 2017 - 2020, USD Million
TABLE 62 Rest of LAMEA Hydrogel-based Drug Delivery System Market, 2021 - 2027, USD Million
TABLE 63 Rest of LAMEA Hydrogel-based Drug Delivery System Market by Polymer Origin, 2017 - 2020, USD Million
TABLE 64 Rest of LAMEA Hydrogel-based Drug Delivery System Market by Polymer Origin, 2021 - 2027, USD Million
TABLE 65 Rest of LAMEA Hydrogel-based Drug Delivery System Market by Delivery Route, 2017 - 2020, USD Million
TABLE 66 Rest of LAMEA Hydrogel-based Drug Delivery System Market by Delivery Route, 2021 - 2027, USD Million
TABLE 67 Key information –Johnson & Johnson
TABLE 68 key information – Bausch Health Companies, Inc.
TABLE 69 Key Information – Medtronic PLC
TABLE 70 Key Information – Galderma S.A.
TABLE 71 key Information – Endo International PLC
TABLE 72 key information – Ferring Holdings SA
TABLE 73 Key information - Akorn Operating Company LLC
TABLE 74 Key Information – Tolmar Pharmaceuticals, Inc.
TABLE 75 Key Information – Blairex Laboratories, Inc.
TABLE 76 Key information - Ocular Therapeutix, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Bausch Health Companies, Inc.